top of page

THE ROLE OF JAKAFI IN STEROID-REFRACTORY ACUTE GVHD

Thu, Dec 05

|

The Capital Grille

Registration is Closed
See other events
THE ROLE OF JAKAFI IN STEROID-REFRACTORY ACUTE GVHD
THE ROLE OF JAKAFI IN STEROID-REFRACTORY ACUTE GVHD

Time & Location

Dec 05, 2019, 5:00 PM – 8:00 PM

The Capital Grille, Hynes Convention Center, 900 Boylston St, Boston, MA 02115, USA

Guests

About The Event

You are cordially invited to attend a program:

THE ROLE OF JAKAFI IN STEROID-REFRACTORY ACUTE GVHD

Presented by: 

Paul Larson, MSN, NP

Program Summary: 

This promotional presentation will review diagnosis, staging, and grading of acute graft-versus-host disease (GVHD), identification of patients with steroid-refractory acute GVHD, and use of Jakafi® (ruxolitinib), a targeted JAK1/JAK2 inhibitor, for these patients. Data from the REACH1 study will be reviewed, along with important safety information for Jakafi.

Share This Event

BONS logo.png

Contact:

Daunielle Ricardi, President

Alissa Gentile, Treasurer

Cameron Keith, Social Media Coordinator

Email: BonsSocialMedia@gmail.com

  • Facebook
  • Instagram
  • LinkedIn
Earthen Media-4.png
bottom of page